Project Grant H79TI085222
- Prism Health North Texas (PHNTX) received a $300,000 Project Grant award effective September 1, 2025, through August 31, 2026, under the HIV-Related Training and Technical Assistance program (CFDA 93.145) administered by the Health Resources and Services Administration's HIV/AIDS Bureau. The award funds PHNTX's FY2025 Ryan White HIV/AIDS Program Part C Capacity Development Grant (HRSA-25-049) to establish sustainable strategic partnerships serving justice-involved individuals living with HIV...
- Federal Grant Award Summary Abounding Prosperity Incorporated received a $926,472 Project Grant award from the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau under the Special Projects of National Significance (SPNS) program (CFDA 93.928), effective August 1, 2025, through July 31, 2029. This demonstration/implementation site award supports Abounding Prosperity Incorporated's delivery of innovative HIV care and treatment models in Dallas, Texas, targeting underserved...
- This $5.37 million project grant from the National Institutes of Health National Institute on Drug Abuse will fund the development of a context-aware digital adherence intervention called SMARTSTEPS to improve pre-exposure prophylaxis (PrEP) adherence among men who have sex with men with substance use disorder. The grant will support two phases. Phase I will inform the specification of an algorithm that utilizes digital phenotyping data from a smartphone app to anticipate non-adherence based...
- The University of North Texas Health Science Center at Fort Worth received a $4.5 million cooperative agreement from the Health Resources and Services Administration HIV/AIDS Bureau under the Special Projects of National Significance (SPNS) program (CFDA 93.928) for the period of August 1, 2025 through July 31, 2029. The SPNS program supports the development and implementation of innovative models of HIV care and treatment designed to address emerging needs of Ryan White HIV/AIDS Program clients...
- PROTECT AL: PrEP Optimization Through Enhanced Continuum Tracking The National Institute of Mental Health awarded the University of Alabama at Birmingham a $790,198 Project Grant on September 18, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop and implement PROTECT AL, a data-driven initiative designed to optimize HIV pre-exposure prophylaxis (PrEP) utilization across Alabama's high-incidence areas. The project, extending through May 31, 2030, delivers a...
- Federal Project Grant Award Summary Abounding Prosperity Incorporated received a $300,000 project grant award from the Health Resources and Services Administration's HIV/AIDS Bureau under the HIV-Related Training and Technical Assistance program (CFDA 93.145) for the period September 1, 2025, through August 31, 2026. The organization will deliver infrastructure development services focused on telehealth capacity expansion to enhance behavioral health service delivery for people living with HIV...
- HOPE CENTER TCE PROJECT GRANT SUMMARY The Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment awarded a $750,000 Project Grant to Hope Center, Inc. under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) on September 30, 2025. Over the three-year project period (through September 29, 2028), Hope Center will provide integrated substance use disorder (SUD) and co-occurring mental...
- Federal Project Grant Summary Award Overview US Helping Us-People Into Living, Inc. received a $2.3 million project grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) on September 30, 2025. The grant funds the three-year HEPC FREE: Corridor of Care initiative, a hepatitis C virus (HCV) elimination program...
- Federal Grant Award Summary Public Health Foundation Enterprises, Inc. (doing business as Heluna Health) received a $588,669 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) on April 15, 2026, with an ultimate completion date of January 31, 2031. The award funds the Street Prep intervention, which delivers evidence-based HIV prevention services directly to people who use drugs and experience homelessness in San...
- Federal Grant Award Summary JPS Health Network received a $8.09 million Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Mental Health Services under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) on September 30, 2025. The three-year initiative, concluding September 29, 2027, supports the Prevention, Access, Treatment and Healing (PATH) Program, a comprehensive...
SUPPORTING TREATMENT, EMPOWERMENT, AND PROGRESS (STEP) - AIDS ARMS, INC. DBA PRISM HEALTH NORTH TEXAS (PHNTX) WILL CONTINUE THE SUPPORTING TREATMENT, EMPOWERMENT AND PROGRESS (STEP) PROGRAM WHOSE PURPOSE IS TO ADDRESS ENGAGEMENT IN CARE FOR BLACK MSM, HISPANIC MSM, WHITE MSM, AND TRANSGENDER INDIVIDUALS WITH SUBSTANCE USE DISORDERS (SUD) AND/OR CO-OCCURRING SUBSTANCE USE AND MENTAL DISORDERS (COD) WHO ARE AT RISK FOR HIV OR HIV POSITIVE, THROUGH AN INTEGRATED MODEL OF BEHAVIORAL HEALTH (BH) AND MEDICAL CARE. THE PROGRAM WILL SERVE AN AVERAGE OF 100 UNDUPLICATED CLIENTS ANNUALLY AND 500 UNDUPLICATED CLIENTS IN TOTAL THROUGH AN INTEGRATED MODEL OF CARE UTILIZING EVIDENCED-BASED PRACTICES (EBP) AND SUPPORTIVE SERVICES. THE EBPS WILL INCLUDE COUNSELING, TESTING AND REFERRAL, SCREENING, BRIEF INTERVENTION AND REFERRAL TO TREATMENT, INTEGRATED TREATMENT FOR CODS, BEHAVIORAL ACTIVATION FOR METHAMPHETAMINE DEPENDENCE, COGNITIVE BEHAVIORAL THERAPY (CBT), CBT FOR HIV MEDICATION ADHERENCE AND DEPRESSION, MOTIVATIONAL INTERVIEWING, AND PEER RECOVERY SUPPORT SERVICES (PRSS). THE SUPPORTIVE SERVICES WILL INCLUDE HIV AND VIRAL HEPATITIS (VH) TESTING AND LINKAGE TO TREATMENT, CASE MANAGEMENT, PREP SERVICES, MEDICAL CARE, INTEGRATED BEHAVIORAL HEALTH, RECOVERY SUPPORT SERVICES, AND LINKAGE TO SUD TREATMENT. IN ADDITION, A PROGRAM ADVISORY BOARD WITH MEMBERSHIP COMPRISED OF PROGRAM PARTICIPANTS WILL PROVIDE FEEDBACK REGARDING PROGRAM DEVELOPMENT AND ENHANCEMENT. THE STEP PROGRAM GOALS, AND MEASURABLE OBJECTIVES INCLUDE: -EXPAND SUD/COD TREATMENT AND RECOVERY SUPPORT SERVICES BY INCREASING ACCESS AND AVAILABILITY TO THE POPULATIONS OF FOCUS. BY 9/29/2027, INCREASE UTILIZATION OF INTEGRATED BH SERVICES FOR 95% OF CLIENTS WHO ARE SCREENED POSITIVE FOR SUD AND/OR COD AND ENROLLED INTO THE PROGRAM. BY 9/29/2027, INCREASE ENGAGEMENT AND RETENTION IN CARE IN 90% OF CLIENTS THROUGH FOCUSED CBT INTERVENTIONS AND PEER RECOVERY SUPPORT SERVICES. BY 9/29/2027, INCREASE PATIENT SELF-EFFICACY IN 85% OF CLIENTS IDENTIFIED THROUGH THE GPRA SURVEY ADMINISTERED AT INTAKE, 6-MONTH FOLLOW-UP, AND DISCHARGE. BY 9/29/2027, DECREASE NEGATIVE SYMPTOMS OF SUD/COD IN 85% OF CLIENTS IDENTIFIED THROUGH EBP SCREENING TOOLS AND GPRA ADMINISTERED AT INTAKE, 6-MONTH FOLLOW-UP, AND DISCHARGE. BY 9/29/2027, PROVIDE SERVICES WITH HIGH-FIDELITY TO EBP BY OBSERVING 100% OF STAFF MONTHLY UTILIZING THE BH OBSERVATION FORM. -INCREASE LINKAGE TO AND ENGAGEMENT IN HIV AND VH TESTING, RISK REDUCTION EDUCATION, CASE MANAGEMENT (CM) SERVICES, PRE-EXPOSURE PROPHYLAXIS (PREP) SERVICES, AND TREATMENT FOR POPULATIONS OF FOCUS AND THEIR DRUG-USING AND/OR SEXUAL PARTNERS. BY 9/29/2027, INCREASE IN NUMBER OF INDIVIDUALS TESTED FOR HIV AND VH THROUGH OUTREACH AND IN-HOUSE TESTING IDENTIFIED THROUGH COMPLETED TESTS IN ELECTRONIC HEALTH RECORD (EHR). BY 9/29/2027, 90% OF HIV POSITIVE CLIENTS ENGAGED IN HIV MEDICAL CARE IDENTIFIED THROUGH APPOINTMENT COMPLETION IN EHR. BY 9/29/2027, 80% OF INDIVIDUALS TESTED POSITIVE FOR HIV LINKED TO INTEGRATED CARE IDENTIFIED THROUGH APPOINTMENT COMPLETION IN EHR. BY 9/29/2027, 100% OF INDIVIDUALS TESTED NEGATIVE FOR HIV LINKED TO PREP SERVICES IDENTIFIED THROUGH APPOINTMENT COMPLETION IN EHR. BY 9/29/2027, 80% OF INDIVIDUALS TESTED POSITIVE FOR VH LINKED TO CASE MANAGEMENT IDENTIFIED THROUGH APPOINTMENT COMPLETION IN EHR. BY 9/29/2027, 95% OF INDIVIDUALS TESTED FOR HIV/VH COMPLETED RISK REDUCTION EDUCATION IDENTIFIED THROUGH EDUCATION COMPLETION IN EHR. BY 9/29/2027, 100% OF INDIVIDUALS TESTED FOR HIV/VH PROVIDED MATERIALS TO REFER DRUG-USING AND/OR SEXUAL PARTNERS TO HIV/VH TESTING IDENTIFIED THROUGH EDUCATION COMPLETION IN EHR.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 2/10/26 | ||
| Not listed | $0 | 1/15/26 | ||
| Not listed | $0 | 1/15/26 | ||
| Not listed | $0 | 1/13/26 | ||
| Not listed | $0 | 1/13/26 |